Saturday, July 11, 2026

pharma · Pancreatic Cancer Non-resectable

Shanghai Proton and

News and analysis for Shanghai Proton and on NovaPharmaNews — regulatory, clinical, and market coverage.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
2
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Shanghai Proton and — regulatory, clinical, and market coverage.

News and analysis for Shanghai Proton and on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Shanghai Proton and yet.

Back to company overview →